EUVIMEDEUVIMED entdecken
CrossrefInfokarte

HIGH TITRE ANTI-A AND ANTI-B ANTIBODIES IN GROUP ‘O’ BLOOD DONORS - A TERTIARY CARE HOSPITAL BLOOD BANK EXPERIENCE

Anum Sharif, Mansoor Ishaq Raja, Waqas Hanif, Muhammad Sajid Yazdani, Hamid Iqbal, Noreen Anwar

Pakistan Journal of Pathology · 2022

DOI: 10.55629/pakjpathol.v33i1.700 ↗
AbstractBibliografische Angaben

Abstract

Objective: To determine the frequency of titre anti-A and anti-B antibodies in donors with blood group O. Material and Methods: The study was conducted at Combined Military Hospital Multan from October 2019 to April 2020. This cross-sectional study has conducted after the approval of ethics review committee; A total of 300 individuals with blood group O reported for blood donation during the study period were considered in this study. After their consent, 10 ml whole blood of each donor was collected in two tubes, 3 ml collected in Ethylenediaminetetraacetic acid (EDTA) tube and 7 ml in plain tube. Anti-A & anti-B antibodies titers were performed using pooled blood group A and B red cells by tube method at room temperature and 37° C. Results: Male consisted of 174 (58%) and female consisted of 126 (42%) with male to female ratio of 1.5:1 out of 300 blood donors. The ages of individuals range from 20 to 50 years (32.8 ± 7.2). The frequencies of titer of anti-A antibodies and anti-B antibodies were found to be 17.7% and 9.0% respectively. Conclusion: Titer of anti-A antibodies is high in considerable number of blood group O donors supports cautious use of Blood group O products in non-O recipients without screening. However, frequency of titer of anti-B antibodies was found to be relatively low. Key Words: Anti-B, Anti-A, High titre, Blood group O, Non-O Blood group.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →